As of 2025-04-30, the EV/EBITDA ratio of DarioHealth Corp (DRIO) is -1.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRIO's latest enterprise value is 30.38 mil USD. DRIO's TTM EBITDA according to its financial statements is -27.02 mil USD. Dividing these 2 quantities gives us the above DRIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 23.0x | 20.7x |
| Forward P/E multiples | 21.6x - 22.9x | 22.2x |
| Fair Price | (14.06) - (14.92) | (13.95) |
| Upside | -2054.3% - -2173.5% | -2038.9% |
| Date | EV/EBITDA |
| 2025-04-29 | -1.12 |
| 2025-04-28 | -1.23 |
| 2025-04-25 | -1.25 |
| 2025-04-24 | -1.28 |
| 2025-04-23 | -1.25 |
| 2025-04-22 | -1.22 |
| 2025-04-21 | -1.14 |
| 2025-04-17 | -1.17 |
| 2025-04-16 | -1.09 |
| 2025-04-15 | -1.10 |
| 2025-04-14 | -1.05 |
| 2025-04-11 | -1.13 |
| 2025-04-10 | -0.87 |
| 2025-04-09 | -0.89 |
| 2025-04-08 | -0.89 |
| 2025-04-07 | -0.91 |
| 2025-04-04 | -0.88 |
| 2025-04-03 | -0.90 |
| 2025-04-02 | -0.99 |
| 2025-04-01 | -0.93 |
| 2025-03-31 | -0.96 |
| 2025-03-28 | -0.98 |
| 2025-03-27 | -1.03 |
| 2025-03-26 | -1.03 |
| 2025-03-25 | -1.04 |
| 2025-03-24 | -1.09 |
| 2025-03-21 | -1.08 |
| 2025-03-20 | -1.10 |
| 2025-03-19 | -1.12 |
| 2025-03-18 | -1.06 |
| 2025-03-17 | -1.07 |
| 2025-03-14 | -1.04 |
| 2025-03-13 | -1.01 |
| 2025-03-12 | -0.99 |
| 2025-03-11 | -0.97 |
| 2025-03-10 | -1.05 |
| 2025-03-07 | -1.14 |
| 2025-03-06 | -1.13 |
| 2025-03-05 | -1.05 |
| 2025-03-04 | -1.02 |
| 2025-03-03 | -1.00 |
| 2025-02-28 | -1.09 |
| 2025-02-27 | -1.06 |
| 2025-02-26 | -1.08 |
| 2025-02-25 | -1.08 |
| 2025-02-24 | -1.08 |
| 2025-02-21 | -1.08 |
| 2025-02-20 | -1.09 |
| 2025-02-19 | -1.10 |
| 2025-02-18 | -1.13 |